Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IASO Trial in acute severe colitis
ISRCTN43717130Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis and Colitis comparing Anakinra + standard corticosteroids with Placebo + standard corticosteroids (2 arms). Primary endpoint: Incidence of medical or surgical rescue therapy within 10 days. Started Feb 2018; status: completed.
02
Drugs
anakinra
03
Conditions
autoimmune colitisColitis
Beyond the preview
Go deeper on ISRCTN43717130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43717130.